TRANSFORMED INDOLENT LYMPHOMA

Clinical trials for TRANSFORMED INDOLENT LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new TRANSFORMED INDOLENT LYMPHOMA trials appear

Sign up with your email to follow new studies for TRANSFORMED INDOLENT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New hope for tough lymphoma: targeted drug combo shows promise in early trial

Disease control Ongoing

This phase 2 trial tests a combination of the targeted drug polatuzumab vedotin with standard chemotherapy (rituximab, ifosfamide, carboplatin, and etoposide) as an initial salvage therapy for patients with diffuse large B-cell lymphoma that has relapsed or not responded to treat…

Matched conditions: TRANSFORMED INDOLENT LYMPHOMA

Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Jun 26, 2026 12:54 UTC

TRANSFORMED INDOLENT LYMPHOMA

Get alerted when new TRANSFORMED INDOLENT LYMPHOMA trials appear

New hope for tough lymphoma: targeted drug combo shows promise in early trial